A worker unloads boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.